BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Total Liabilities 2023–2025
BridgeBio Oncology Therapeutics, Inc. annual total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- BridgeBio Oncology Therapeutics, Inc. total liabilities as of December 31, 2025: 37.3M, a 89.13% decrease year-over-year.
- BridgeBio Oncology Therapeutics, Inc. total liabilities for 2025 were 37.3M, a 89.13% decrease from 2024.
- BridgeBio Oncology Therapeutics, Inc. total liabilities for 2024 were 342.9M, a 182.06% increase from 2023.
- BridgeBio Oncology Therapeutics, Inc. total liabilities for 2023 were 121.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Oncology Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $37 |
| 2024 | $343 |
| 2023 | $122 |
BridgeBio Oncology Therapeutics, Inc. Total Liabilities — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's total liabilities history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.